Enhanced membrane-tethered mucin 3 (MUC3) expression by a tetrameric branched peptide with a conserved tflk motif inhibits bacteria adherence

Journal of Biological Chemistry

Volumn 288, Issue 8, 2013, Pages 5407-5416

  Pan, Qiong ^a,b   Tian, Yin ^a   Li, Xiaohuan ^a   Ye, Jun ^a   Liu, Yun ^a,b   Song, Lili ^a,b   Yang, Yongtao ^a,b   Zhu, Rong ^a   He, Yonghong ^a,b   Chen, Lei ^a,b   Chen, Wensheng ^a,b   Mao, Xuhu ^a,b   Peng, Zhihong ^a,b   Wang, Rongquan ^a,b  

^a SOUTHWEST HOSPITAL   (China)

^b THIRD MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

GASTROINTESTINAL INFECTIONS; TETRAMERIC; THERAPEUTIC VALUES; TRANSCRIPTIONAL MECHANISMS;

BACTERIA;

PEPTIDES;

MAMMARY ASSOCIATED SERUM AMYLOID A3; MUCIN 3; SERUM AMYLOID A; SYNTHETIC PEPTIDE; THREONYLPHENYLALANYLLEUCYLLYSINE; UNCLASSIFIED DRUG;

AMINO TERMINAL SEQUENCE; ANTIBACTERIAL ACTIVITY; ARTICLE; BACTERIUM ADHERENCE; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; DNA MICROARRAY; ENTEROHEMORRHAGIC ESCHERICHIA COLI; ENTEROPATHOGENIC ESCHERICHIA COLI; ENZYME ASSAY; GEL MOBILITY SHIFT ASSAY; GENE EXPRESSION; GENE INTERACTION; GENETIC CONSERVATION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; IN VITRO STUDY; MUC3 GENE; NONHUMAN; PEPTIDE ANALYSIS; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN INTERACTION; PROTEIN MOTIF; REAL TIME POLYMERASE CHAIN REACTION; SEROTYPE; SOLID PHASE SYNTHESIS; UPREGULATION; WESTERN BLOTTING;

AMINO ACID MOTIFS; BACTERIAL ADHESION; ESCHERICHIA COLI; ESCHERICHIA COLI O157; GASTROINTESTINAL TRACT; GENE EXPRESSION REGULATION; HT29 CELLS; HUMANS; MODELS, GENETIC; MUCIN-3; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PEPTIDES; PROMOTER REGIONS, GENETIC; REAL-TIME POLYMERASE CHAIN REACTION; TRANSCRIPTION, GENETIC;

EID: 84874341083     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M112.408245     Document Type: Article

References (37)

1. Kim, Y. S., Ho, S. B. (2010) Intestinal goblet cells and mucins in health and disease. Recent insights and progress. Curr. Gastroenterol. Rep. 12, 319-330
2. Lindén, S. K., Florin, T. H., McGuckin, M. A. (2008) Mucin dynamics in intestinal bacterial infection. PLoS One 3, e3952
3. Lieleg, O., Lieleg, C., Bloom, J., Buck, C. B., Ribbeck, K. (2012) Mucin biopolymers as broad-spectrum antiviral agents. Biomacromolecules 13, 1724-1732
4. Mack, D. R., Michail, S., Wei, S., McDougall, L., Hollingsworth, M. A. (1999) Probiotics inhibit enteropathogenic E. coli adherence in vitro by inducing intestinal mucin gene expression. Am. J. Physiol. 276, G941-G950
5. Velcich, A., Palumbo, L., Jarry, A., Laboisse, C., Racevskis, J., Augenlicht, L. (1995) Patterns of expression of lineage-specific markers during the in vitro induced differentiation of HT29 colon carcinoma cells. Cell Growth Differ. 6, 749-757
6. Ho, S. B., Luu, Y., Shekels, L. L., Batra, S. K., Kandarian, B., Evans, D. B., Zaworski, P. G., Wolfe, C. L., Heinrikson, R. L. (2010) Activity of recombinant cysteine-rich domain proteins derived from the membrane-bound MUC17/Muc3 family mucins. Biochim. Biophys. Acta 1800, 629-638
7. Luu, Y., Junker, W., Rachagani, S., Das, S., Batra, S. K., Heinrikson, R. L., Shekels, L. L., Ho, S. B. (2010) Human intestinal MUC17 mucin augments intestinal cell restitution and enhances healing of experimental colitis. Int. J. Biochem. Cell Biol. 42, 996-1006
8. Caballero-Franco, C., Keller, K., De Simone, C., Chadee, K. (2007) The VSL#3 probiotic formula induces mucin gene expression and secretion in colonic epithelial cells. Am. J. Physiol. Gastrointest. Liver Physiol. 292, G315-G322
9. Mack, D. R., Ahrne, S., Hyde, L., Wei, S., Hollingsworth, M. A. (2003) Extracellular MUC3 mucin secretion follows epithelial cells in vitro adherence of Lactobacillus strains to intestinal. Gut 52, 827-833
10. Playford, R. J., Macdonald, C. E., Johnson, W. S. (2000) Colostrum and milk-derived peptide growth factors for the treatment of gastrointestinal disorders. Am. J. Clin. Nutr. 72, 5-14
11. Bodammer, P., Maletzki, C., Waitz, G., Emmrich, J. (2011) Prophylactic application of bovine colostrum ameliorates murine colitis via induction of immunoregulatory cells. J. Nutr. 141, 1056-1061
12. Rawal, P., Gupta, V., Thapa, B. R. (2008) Role of colostrum in gastrointestinal infections. Indian J. Pediatr. 75, 917-921
13. Møller, H. K., Thymann, T., Fink, L. N., Frokiaer, H., Kvistgaard, A. S., Sangild, P. T. (2011) Bovine colostrum is superior to enriched formulas in stimulating intestinal function and necrotising enterocolitis resistance in preterm pigs. Br. J. Nutr. 105, 44-53
14. Mack, D. R., McDonald, T. L., Larson, M. A., Wei, S., Weber, A. (2003) The conserved TFLK motif of mammary-associated serum amyloid a3 is responsible for up-regulation of intestinal MUC3 mucin expression in vitro. Pediatr. Res. 53, 137-142
15. Gardiner, G. E., O'Flaherty, S., Casey, P. G., Weber, A., McDonald, T. L., Cronin, M., Hill, C., Ross, R. P., Gahan, C. G., Shanahan, F. (2009) Evaluation of colostrum-derived human mammary-associated serum amyloid A3 (M-SAA3) protein and peptide derivatives for the prevention of enteric infection. In vitro and in murine models of intestinal disease. FEMS Immunol. Med. Microbiol. 55, 404-413
16. Larson, M. A., Wei, S. H., Weber, A., Mack, D. R., McDonald, T. L. (2003) Human serum amyloid A3 peptide enhances intestinal MUC3 expression and inhibits EPEC adherence. Biochem. Biophys. Res. Commun. 300, 531-540
17. Ruvo, M., Sandomenico, A., Tudisco, L., De Falco, S. (2011) Branched peptides for the modulation of protein-protein interactions. More arms are better than one? Curr. Med. Chem. 18, 2429-2437
18. Jin, Z. H., Furukawa, T., Waki, A., Akaji, K., Coll, J. L., Saga, T., Fujibayashi, Y. (2010) Effect of multimerization of a linear Arg-Gly-Asp peptide on integrin binding affinity and specificity. Biol. Pharm. Bull. 33, 370-378
19. Falciani, C., Lozzi, L., Pini, A., Corti, F., Fabbrini, M., Bernini, A., Lelli, B., Niccolai, N., Bracci, L. (2007) Molecular basis of branched peptides resistance to enzyme proteolysis. Chem Biol. Drug Des. 69, 216-221
20. Mack, D.R., Hollingsworth, M. A. (1994) Alteration in expression of MUC2 and MUC3 mRNA levels in HT29 colonic carcinoma cells. Biochem. Biophys. Res. Commun. 199, 1012-1018
21. Gout, S., Marie, C., Lainé, M., Tavernier, G., Block, M. R., Jacquier-Sarlin, M. (2004) Early enterocytic differentiation of HT-29 cells. Biochemical changes and strength increases of adherens junctions. Exp. Cell Res. 299, 498-510
22. Sakai, H., Hirahara, M., Chiba, Y., Misawa, M. (2011) Antigen challenge influences various transcription factors of rat bronchus. Protein/DNA array study. Int. Immunopharmacol. 11, 1133-1136
23. Chai, J., He, Y., Cai, S. Y., Jiang, Z., Wang, H., Li, Q., Chen, L., Peng, Z., He, X., Wu, X., Xiao, T., Wang, R., Boyer, J. L., Chen, W. (2012) Elevated hepatic multidrug resistance-associated protein 3/ATP-binding cassette subfamily C 3 expression in human obstructive cholestasis is mediated through tumor necrosis factor-and c-Jun NH2-terminal kinase/stressactivated protein kinase-signaling pathway. Hepatology 55, 1485-1494
24. Böhm, S. K., Gum, J. R. Jr., Erickson, R. H., Hicks, J. W., Kim, Y. S. (1995) Human dipeptidyl peptidase IV gene promoter: Tissue-specific regulation from a TATA-less GC-rich sequence characteristic of a housekeeping gene promoter. Biochem. J. 311, 835-843
25. Traber, P. G., Silberg, D. G. (1996) Intestine-specific gene transcription. Annu. Rev. Physiol. 58, 275-297
26. Erickson, R. H., Lai, R. S., Lotterman, C. D., Kim, Y. S. (2000) Identification of upstream stimulatory factor as an activator of the human dipeptidyl peptidase IV gene in Caco-2 cells. Gene 258, 77-84
27. Gum, J. R., Hicks, J. W., Kim, Y. S. (1997) Identification and characterization of the MUC2 (human intestinal mucin) gene 5'-flanking region. Promoter activity in cultured cells. Biochem. J. 325, 259-267
28. Domènech, A., Raynes, J. G., Rodríguez, E. G., Arís, A., Bach, A., Serrano, A. (2012) Recombinant expression of goat milk serum amyloid A. Preliminary studies of the protein and derived peptides on macrophage phagocytosis. Protein Pept. Lett. 19, 299-307
29. Edwards, P. J. (2009) Current parallel chemistry principles and practice. Application to the discovery of biologically active molecules. Curr. Opin. Drug Discov. Devel. 12, 899-914
30. Shin, D. S., Kim, D. H., Chung, W. J., Lee, Y. S. (2005) Combinatorial solid phase peptide synthesis and bioassays. J. Biochem. Mol. Biol. 38, 517-525
31. Ponticelli, S., Marasco, D., Tarallo, V., Albuquerque, R. J., Mitola, S., Takeda, A., Stassen, J. M., Presta, M., Ambati, J., Ruvo, M., De Falco, S. (2008) Modulation of angiogenesis by a tetrameric tripeptide that antagonizes vascular endothelial growth factor receptor 1. J. Biol. Chem. 283, 34250-34259
32. Pini, A., Falciani, C., Mantengoli, E., Bindi, S., Brunetti, J., Iozzi, S., Rossolini, G. M., Bracci, L. (2010) A novel tetrabranched antimicrobial peptide that neutralizes bacterial lipopolysaccharide and prevents septic shock in vivo. FASEB J. 24, 1015-1022
33. Shekels, L. L., Ho, S. B. (2003) Characterization of the mouse Muc3 membrane bound intestinal mucin 5'-coding and promoter regions. Regulation by inflammatory cytokines. Biochim. Biophys. Acta 1627, 90-100
34. Gum, J. R. Jr., Hicks, J. W., Crawley, S. C., Dahl, C. M., Yang, S. C., Roberton, A. M., Kim, Y. S. (2003) Initiation of transcription of the MUC3A human intestinal mucin from a TATA-less promoter and comparison with the MUC3B amino terminus. J. Biol. Chem. 278, 49600-49609
35. Guerrant, R. L., Hughes, J. M., Lima, N. L., and Crane, J. (1990) Diarrhoea in developed and developing countries. Magnitude, special setting, and etiologies. Rev. Infect. Dis. 12, S41-S51
36. Jarvis, K.G., Girón, J. A., Jerse, A. E., McDaniel, T. K., Donnenberg, M. S., Kaper, J. B. (1995) Enteropathogenic Escherichia coli contains a putative type III secretion system necessary for the export of proteins involved in attaching and effacing lesion formation. Proc. Natl. Acad. Sci. U.S.A. 92, 7996-8000
37. Ho, N. K., Ossa, J. C., Silphaduang, U., Johnson, R., Johnson-Henry, K. C., Sherman, P. M. (2012) Enterohemorrhagic Escherichia coli O157:H7 Shiga toxins inhibit-interferon-mediated cellular activation. Infect. Immun. 80, 2307-2315